BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 15126170)

  • 1. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
    Dudney BW; Malecha MA
    Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of ocular surface squamous neoplasia with Mitomycin C.
    Gupta A; Muecke J
    Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
    Tseng SH; Tsai YY; Chen FK
    Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
    Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
    Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
    Lichtinger A; Pe'er J; Frucht-Pery J; Solomon A
    Ophthalmology; 2010 Mar; 117(3):431-7. PubMed ID: 20060167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
    Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN
    Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Wilson MW; Hungerford JL; George SM; Madreperla SA
    Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
    Tunc M; Erbilen E
    Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
    Lee JH; Kim YH; Kim MS; Kim EC
    Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin C therapy for corneal intraepithelial neoplasia masquerading as limbal stem cell deficiency with recurrent epithelial defect.
    Gokhale NS
    Int Ophthalmol; 2011 Apr; 31(2):161-3. PubMed ID: 21327677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limbal stem cell deficiency after subconjunctival mitomycin C injection for trabeculectomy.
    Sauder G; Jonas JB
    Am J Ophthalmol; 2006 Jun; 141(6):1129-30. PubMed ID: 16765685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
    Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
    Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia.
    Papandroudis AA; Dimitrakos SA; Stangos NT
    Cornea; 2002 Oct; 21(7):715-7. PubMed ID: 12352093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical excision, cryotherapy, autolimbal transplantation and mitomycin-C in treatment of conjunctival-corneal intraepithelial neoplasia.
    Doganay S; Er H; Tasar A; Gürses I
    Int Ophthalmol; 2005; 26(1-2):53-7. PubMed ID: 16779567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
    Haas K; Ben-Dor D; Levartovsky S
    Arch Ophthalmol; 1999 Apr; 117(4):544-5. PubMed ID: 10206591
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.
    Di Pascuale MA; Espana EM; Tseng SC
    Cornea; 2004 Jan; 23(1):89-92. PubMed ID: 14701965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
    Rodríguez-Pérez C; Del Campo Z; Wolley-Dod C; Gris O
    Arch Soc Esp Oftalmol; 2002 Dec; 77(12):685-8. PubMed ID: 12471516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
    Shields CL; Naseripour M; Shields JA
    Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.